Chemoradiation Helps Most Early Rectal Cancer Patients Avoid Surgery

In a randomized trial, nearly 80% of patients with early-stage rectal cancer who received chemoradiation avoided surgery for at least a year, compared with 60% who had short-course radiotherapy alone. Both organ-preserving approaches had low rates of serious side effects. The results support a deliberate strategy of trying to preserve the rectum in suitable patients.